Integral Health Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Integral Health Asset Management’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-70,000	Closed	-$4.89M	–	90
2022 Q3	$4.89M	Buy	+70,000	New	+$5.18M	0.95%	41
2021 Q4	–	Sell	-20,000	Closed	-$3.54M	–	87
2021 Q3	$3.54M	Sell	20,000 -30,000	-60%	-$4.83M	1.02%	42
2021 Q2	$8.08M	Hold	50,000	–	–	2.22%	14
2021 Q1	$8.56M	Buy	50,000 +13,000	+35%	+$2.57M	2.45%	14
2020 Q4	$8.13M	Buy	37,000 +7,000	+23%	+$1.51M	2.42%	17
2020 Q3	$4.98M	Sell	30,000 -20,000	-40%	-$2.74M	1.52%	23
2020 Q2	$5.71M	Buy	50,000 +10,000	+25%	+$970K	1.71%	28
2020 Q1	$3.08M	Buy	40,000 +25,000	+167%	+$2.24M	1.35%	34
2019 Q4	$1.93M	Buy	+15,000	New	+$1.45M	0.75%	38

Other funds holding MRTX

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Integral Health Asset Management's MRTX Position: Q4 2022 in Review

Integral Health Asset Management sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q4 2022, closing a stake of 70,000 shares — an estimated $4.89M sold.

Integral Health Asset Management first reported a position in MRTX in Q4 2019 and held it in 9 quarters. The position peaked at $8.56M in Q1 2021. 233 funds tracked by Wall St. Rank hold MRTX as of Q4 2022.

Integral Health Asset Management reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Integral Health Asset Management sold 70,000 Mirati Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $4.89M.
Integral Health Asset Management first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2019 and held it in 9 quarters.
Integral Health Asset Management's Mirati Therapeutics, Inc. Common Stock position peaked at $8.56M in Q1 2021.
233 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Integral Health Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.